Retour
Prix Akeso Inc (AKESF)
Graphique du cours de l'action AKESF
AKESF Gagner
Akeso Inc
$15.47
-0.19%
$-0.02
À la fermeture : Jan 16, 16:00:00 GMT-5
$15.55
0.51%
$0.08
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$15.5
Prix d'ouverture
$15.53
Plage de la journée
$15.47 - $16.1
Plage de 52 semaines
$6.81 - $23.15
Volume
--
Volume moyen
1.1K
BPA (TTM)
-0.14
Rendement en dividend
--
Capitalisation boursière
$14.3B
Qu’est-ce que AKESF ?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved